Yangling Keyspharma Co.Limited, established in 2011, has expanded a compositive entity from initially only as a small laboratory. The company dedicated to the development, production and marketing of chemicals. Main products Roflumilast (CAS?162401-32-3);Roflumilast InterMediate (CAS:162401-62-9);Hydroxytyrosol (CAS:10597-60-1);Sclareolide(CAS:564-20-5);(?)-Ambroxide(CAS:6790-58-5).
Keyspharma focus on:
-Organic compounds
-Active Pharmaceutical Ingredient(s)
-Nutritional products
-Custom synthesis
-Contract Manufacturing